Diabetic nephropathy market was valued at $3,177.9 million in 2025 and is projected to reach $5,515.8 million by 2035, growing at a CAGR of 5.2% during the forecast period (2026-2035). The Diabetic Nephropathy market is driven by rising diabetes prevalence, early diagnosis, expanding healthcare programs, and increasing chronic disease management. Therapeutic advancements including SGLT2 inhibitors, GLP-1 receptor agonists, and nsMRAs like Finerenone—are the key growth driver, offering improved kidney protection, reduced proteinuria, and better cardiovascular outcomes, fueling global market adoption.

Biometric systems market was valued at $53.4 billion in 2025 and is projected to reach $169.4 billion by 2035, growing at a CAGR of 12.2% during the forecast period (2026-2035). The biometrics market is driven by rising digital identity adoption, increasing identity fraud, expansion of e-government programs, growing use in banking and fintech, and demand for secure, contactless authentication. Among these, AI-powered biometric technologies have emerged as the key growth driver, enabling advanced liveness detection and anti-spoofing capabilities to counter deepfakes and next-generation fraud threats.

European 5G IoT market was valued at $1,760.5 million in 2025 and is projected to reach $43,207.8 million by 2035, growing at a CAGR of 30.5% during the forecast period (2026–2035).The European 5G IoT market is driven by 5G network expansion, smart devices, connected logistics, smart cities, and supportive regulations. Industrial Digitalization and Industry 4.0 adoption emerge as the key growth driver, as manufacturers use 5G IoT for digital twins, predictive maintenance, robotics, and AGVs to boost efficiency, productivity, and safety.

Refurbished medical devices market was valued at $17,894.5 million in 2025 and is projected to reach $34,704.8 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The demand for refurbished medical devices is driven by cost savings, faster availability, and access to high-end technology with lower maintenance requirements. Increasingly, environmental concerns are the dominant factor, as refurbishment reduces CO2 emissions, conserves critical metals, and minimizes hazardous waste, making sustainability a key driver in this market.

US dental care equipment market was valued at $2,880.1 million in 2025 and is projected to reach $5,010.6 million by 2035, growing at a CAGR of 5.7% during the forecast period (2026–2035). Dental care equipment encompasses a broad portfolio of products used in preventive, diagnostic, restorative, and surgical dentistry, including dental chairs and units, digital imaging systems (intraoral X-ray, panoramic X-ray, CBCT), CAD/CAM systems, lasers, handpieces, and infection control equipment. Market growth is driven by the high prevalence of dental caries and periodontal diseases, rising demand for cosmetic and restorative procedures, strong penetration of dental insurance, and rapid adoption of advanced digital dentistry technologies across the United States.

UK dental care equipment market was valued at $327.4 million in 2025 and is projected to reach $509.6 million by 2035, growing at a CAGR of 4.6% during the forecast period (2026–2035). Dental care equipment in the UK encompasses dental chairs and units, imaging systems (intraoral X-ray, panoramic X-ray, CBCT), CAD/CAM systems, lasers, handpieces, and sterilization equipment used across preventive, diagnostic, and restorative dental procedures. Market growth is supported by the high burden of dental caries and periodontal disease, steady demand for restorative and cosmetic dentistry, and ongoing modernization of dental clinics across NHS and private practices.

Latin America dental care equipment market was valued at $664.6 million in 2025 and is projected to reach $1,135.7 million by 2035, growing at a CAGR of 5.5% during the forecast period (2026–2035). Dental care equipment encompasses dental chairs and units, imaging systems (intraoral X-ray, panoramic X-ray, CBCT), CAD/CAM systems, lasers, handpieces, and sterilization solutions, used for preventive, diagnostic, and therapeutic dental procedures. Market growth is driven by increasing awareness of oral health, rising prevalence of dental disorders, expanding dental clinic infrastructure, and gradual adoption of advanced technologies across countries such as Brazil, Mexico, and Argentina.

Japan dental care equipment market was valued at $690.7 million in 2025 and is projected to reach $1,098.2 million by 2035, growing at a CAGR of 4.8% during the forecast period (2026–2035). The market includes a wide range of dental equipment such as dental chairs and units, imaging systems (intraoral X-ray, panoramic X-ray, CBCT), CAD/CAM systems, lasers, handpieces, and sterilization tools used in preventive, diagnostic, and therapeutic dental procedures. Growth is being driven by Japan’s well-established dental infrastructure, high patient awareness of oral health, rising demand for cosmetic and restorative dentistry, and strong adoption of advanced digital technologies in dental practices.

India dental care equipment market was valued at $584.2 million in 2025 and is projected to reach $1,256.5 million by 2035, growing at a CAGR of 8.0% during the forecast period (2026–2035). Dental care equipment in India comprises dental chairs and units, imaging systems such as intraoral X-ray and CBCT, CAD/CAM solutions, lasers, handpieces, and sterilization devices used across preventive, diagnostic, restorative, and cosmetic dental procedures. Market growth is driven by rising prevalence of dental caries and periodontal diseases, increasing awareness of oral hygiene, expanding private dental clinic networks, and gradual adoption of advanced digital dentistry technologies.

global Interleukin inhibitors market was valued at $35,318.2 million in 2025 and is projected to reach $101,185.5 million by 2035, growing at a CAGR of 11.2% during the forecast period (2026-2035). Interleukin inhibitors are targeted biologic therapies designed to block specific interleukins involved in inflammatory and autoimmune pathways, treating conditions such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, and other chronic inflammatory disorders. Market growth is driven by the rising prevalence of autoimmune diseases, increasing adoption of biologics over conventional therapies, ongoing research and development of novel interleukin-targeting drugs, and expanded access through improved healthcare infrastructure globally.